Abstract
A comprehensive quality control program in therapeutic drug monitoring, as in every other area of the clinical laboratory, must concern itself with each step of the analytic process, beginning with the preparation of the patient and ending with the reporting of results to the clinician. Thus, a quality control program must include not only a daily analysis of quality control materials and participation in interlaboratory survey programs but also various other components that are essential in assuring reliable results. A discussion of each of these quality control components is presented.

This publication has 0 references indexed in Scilit: